Statizoid

Health in Mus

270 indicators covering health for Mus.

IndicatorLatest Year10-yr change Rank
Medical doctors 30.15 2023 up 90.2% 1st
Adolescent birth rate 0.4464 2023 down 31.1% 2nd
Reported number of people receiving antiretroviral therapy 3,671 2025 up 45.6% 2nd
Prevalence of insufficient physical activity among adults aged 18+ 31.5% 2022 up 10.6% 2nd
Prevalence of insufficient physical activity among adults aged 18+ 29.9% 2022 up 5.3% 2nd
Nursing and midwifery personnel 35.01 2023 up 14.0% 1st
TB patients with known HIV status 100.0% 2024 up 4.2% 1st
Dentists 3.24 2022 up 38.5% 1st
Number of people dying from HIV-related causes 540 2025 up 8.0% 1st
Confirmed cases of RR-/MDR-TB 0 2024 down 100.0% 2nd
Tested TB patients HIV-positive 9.6% 2024 down 20.0% 2nd
Births attended by skilled health personnel 99.8% 2023 down 0.2% 2nd
Number of new leprosy cases 2 2025 — 2nd
New cases tested for RR-/MDR-TB 100.0% 2024 unchanged 1st
Pharmacists 536 2019 up 38.9% 1st
Age-standardized suicide rates 9.56 2021 up 6.3% 2nd
Number of deaths in children aged <5 years, by cause 53.31 2021 down 12.8% 1st
Premature deaths due to noncommunicable diseases (NCD) as a 47.85 2021 down 5.8% 2nd
Probability (%) of dying between age 30 and exact age 70 from any of 21.7% 2021 down 9.2% 1st
Total NCD Deaths 9,750 2021 up 24.5% 1st
Life expectancy at age 60 19.87 2021 up 1.5% 1st
Age-standardized NCD mortality rate 566.71 2021 down 6.1% 1st
Mortality rate attributed to unintentional poisoning 0.8193 2021 up 10.7% 1st
Life expectancy at birth 73.42 2021 down 0.1% 1st
Adult mortality rate (probability of dying between 15 and 60 years) 160.09 2021 up 4.7% 2nd
Previously treated cases tested for RR-/MDR-TB 100.0% 2022 unchanged 1st
Healthy life expectancy (HALE) at age 60 14.69 2021 up 0.8% 1st
nMx - age-specific death rate between ages x and x+n 0.014 2021 up 7.1% 2nd
lx - number of people left alive at age x 100,000 2021 unchanged 1st
Tx - person-years lived above age x 7.34 million 2021 down 0.1% 1st
nqx - probability of dying between ages x and x+n 0.0138 2021 up 7.0% 2nd
Healthy life expectancy (HALE) at birth 63.63 2021 down 0.4% 1st
nLx - person-years lived between ages x and x+n 98,758 2021 down 0.1% 1st
ex - expectation of life at age x 73.42 2021 down 0.1% 1st
ndx - number of people dying between ages x and x+n 1,381 2021 up 7.0% 2nd
Number of people notified with new episode of TB in a given year 91 2021 down 21.6% 2nd
Number of people diagnosed with new episode of pulmonary TB who are 0 2021 down 100.0% 2nd
Number of people diagnosed with new episode of pulmonary TB who have 5 2021 down 37.5% 2nd
Cases started on MDR-TB treatment 0 2024 down 100.0% 2nd
Number of people diagnosed with new episode of pulmonary TB who are 86 2021 down 14.0% 1st
Raised fasting blood glucose (>=7.0 mmol/L) 13 2014 up 9.2% 1st
Mean fasting blood glucose (mmol/l) 6.15 2014 up 3.1% 1st
Raised fasting blood glucose (>= 7.0 mmol/L) 14.2 2014 up 25.7% 1st
Reported number of people requiring interventions against NTDs 9,918 2024 — 1st
Percentage of total deaths due to NCDs overall and percentage of 15.27 2021 up 69.6% 1st
Pharmacists 4.17 2019 up 38.1% 1st
Number of current cigarette smokers, estimate 146,000 2030 down 18.9% 1st
Inactivated first-dose polio vaccine (IPV1) immunization coverage 98.0% 2025 — 1st
New leprosy case detection rate per 1 000 000 population 1.58 2025 — 2nd
Reported number of children receiving antiretroviral therapy 50 2025 up 108.3% 1st
Low birth weight number 2.5 2020 down 16.7% 1st
Concentrations of fine particulate matter 8.16 2023 down 6.2% 2nd
New or unknown treatment history cases: Pulmonary, bacteriologically 99 2023 down 16.1% 1st
Medical doctors not further defined 3,840 2023 up 87.7% 1st
Leprosy registered prevalence rate per 1 000 000 population 2.37 2025 — 2nd
Leprosy - Number of cases registered for treatment 3 2025 — 2nd
Estimate of current cigarette smoking prevalence 13.8% 2030 down 18.8% 1st
Estimate of current cigarette smoking prevalence (%) 14.5% 2030 down 15.7% 1st
Leprosy - Number of new leprosy cases among children 0 2025 — 1st
New leprosy child case detection rate (less than 15 years of age) per 0 2025 — 1st